Safety and Tolerability of an SQ-Standardized GRAss ALlergy Immunotherapy Tablet (GRAZAX®) in a Real-Life Setting for Three Consecutive Seasons – The GRAAL Trial

Treatment of grass pollen allergy: focus on a standardized grass allergen extract – Grazax®

(2016) Moisés Calderón   Therapeutics and Clinical Risk Management

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

(2012) Stephen R. Durham et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Sublingual Immunotherapy in Patients with Allergic Rhinoconjunctivitis

(2011) Deborah Gentile et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitis

(2011) Alain Didier et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet

(2010) Stephen R. Durham et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Un tiers des adultes ont une rhinite allergique en France (enquête INSTANT)

(2009) Jean-Michel Klossek et al.   PRESSE MEDICALE

Grazax® – Immunothérapie spécifique sous forme de lyophilisat oral d’un extrait de fléole dans la prise en charge de l’allergie aux pollens de graminées : étude observationnelle en médecine ambulatoire

(2009) A. Magnan et al.   Revue Francaise d Allergologie

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

(2008) J. Bousquet et al.   ALLERGY

The diagnosis and management of rhinitis: An updated practice parameter

(2008) D WALLACE et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years

(2008) Ronald Dahl et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY